Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
[Vitamin D and multiple sclerosis].
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Regional anesthesia in patients with pre-existing neurologic disease.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Pregnancy and multiple sclerosis.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?
[New and emerging treatments for multiple sclerosis].
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.

Pages